Metabolic and Appetite Effects of Fructose and Glucose in Subjects with Type 1 Diabetes: A Randomized Crossover Clinical Trial.


Journal

Current diabetes reviews
ISSN: 1875-6417
Titre abrégé: Curr Diabetes Rev
Pays: United Arab Emirates
ID NLM: 101253260

Informations de publication

Date de publication:
2021
Historique:
received: 10 07 2020
revised: 07 10 2020
accepted: 24 10 2020
pubmed: 3 12 2020
medline: 7 8 2021
entrez: 2 12 2020
Statut: ppublish

Résumé

Fructose has been widely used for producing lower post-infusion glucose increase than other carbohydrates, but it seems that it promotes an increase in post-infusion triglycerides. The present study investigated the effects of fructose and glucose in metabolic variables and appetite sensations in patients with type 1 diabetes mellitus (T1DM). This is a single-blind, randomized, and crossover study (washout of 1-5 weeks), which evaluated 16 adult T1DM patients, accompanied at University Hospital. After eight hours of overnight fasting, there was an assessment of capillary blood glucose, anthropometric variables, appetite sensations, and laboratory tests (glycemia, lipemia, leptin and glucagon) were conducted. Subsequently, they received 200mL of solutions with water and 75g of crystal fructose or glucose. Appetite sensations and capillary blood glucose were evaluated in different post-infusion times. Blood was drawn after 180 minutes for the laboratory tests. Blood glucose increased after the intake of both solutions, but glucose induced a higher elevation. None of them increased triglycerides or glucagon. Glucagon maintenance was similar among the solutions. Furthermore, both solutions reduced leptin and increased fullness, but only fructose increased the lack of interest in eating sweets. Fructose induced a smaller increase in postprandial blood glucose than glucose, without changes in triglycerides and glucagon. In addition, leptin levels and appetite sensations were similar to glucose. Other studies are needed in order to confirm these findings, especially in the long term, so that their use becomes really reliable.

Sections du résumé

BACKGROUND BACKGROUND
Fructose has been widely used for producing lower post-infusion glucose increase than other carbohydrates, but it seems that it promotes an increase in post-infusion triglycerides.
OBJECTIVE OBJECTIVE
The present study investigated the effects of fructose and glucose in metabolic variables and appetite sensations in patients with type 1 diabetes mellitus (T1DM).
METHODS METHODS
This is a single-blind, randomized, and crossover study (washout of 1-5 weeks), which evaluated 16 adult T1DM patients, accompanied at University Hospital. After eight hours of overnight fasting, there was an assessment of capillary blood glucose, anthropometric variables, appetite sensations, and laboratory tests (glycemia, lipemia, leptin and glucagon) were conducted. Subsequently, they received 200mL of solutions with water and 75g of crystal fructose or glucose. Appetite sensations and capillary blood glucose were evaluated in different post-infusion times. Blood was drawn after 180 minutes for the laboratory tests.
RESULTS RESULTS
Blood glucose increased after the intake of both solutions, but glucose induced a higher elevation. None of them increased triglycerides or glucagon. Glucagon maintenance was similar among the solutions. Furthermore, both solutions reduced leptin and increased fullness, but only fructose increased the lack of interest in eating sweets.
CONCLUSION CONCLUSIONS
Fructose induced a smaller increase in postprandial blood glucose than glucose, without changes in triglycerides and glucagon. In addition, leptin levels and appetite sensations were similar to glucose. Other studies are needed in order to confirm these findings, especially in the long term, so that their use becomes really reliable.

Identifiants

pubmed: 33261542
pii: CDR-EPUB-111956
doi: 10.2174/1573399816666201201092334
doi:

Substances chimiques

Blood Glucose 0
Insulin 0
Fructose 30237-26-4
Glucose IY9XDZ35W2

Types de publication

Clinical Trial Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e113020188536

Subventions

Organisme : Carlos Chagas Filho Foundation Research Support of Rio de Janeiro State (FAPERJ)
ID : E-26/103.026/2012

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Érika Dos Santos Lima (É)

Nutrition Institute Josue de Castro, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-901, Brazil.

Débora Lopes Souto (DL)

Nutrition Institute Josue de Castro, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-901, Brazil.

Melanie Rodacki (M)

Medicine Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-901, Brazil.

Joana Rodrigues Dantas Pereira (JRD)

Medicine Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-901, Brazil.

Lenita Zajdenverg (L)

Medicine Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-901, Brazil.

Eliane Lopes Rosado (EL)

Nutrition Institute Josue de Castro, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-901, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH